US Stock MarketDetailed Quotes

EIGRQ Eiger BioPharmaceuticals

Watchlist
  • 11.290
  • +0.090+0.80%
15min DelayClose Jul 5 16:00 ET
16.72MMarket Cap-222P/E (TTM)

Eiger BioPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
16.98%15.77M
41.06%3.8M
-20.25%3.21M
13.49%4.64M
54.06%4.12M
11.05%13.48M
-19.76%2.7M
32.41%4.02M
95.09%4.09M
-26.69%2.67M
Operating revenue
21.90%15.52M
41.06%3.8M
-20.25%3.21M
31.49%4.39M
54.06%4.12M
4.88%12.73M
-19.76%2.7M
32.41%4.02M
59.32%3.34M
-26.69%2.67M
Cost of revenue
-98.69%24K
-70.72%101K
-90.66%115K
-305.30%-310K
7.27%118K
146.58%1.84M
231.73%345K
287.11%1.23M
-44.07%151K
107.55%110K
Gross profit
35.22%15.75M
57.46%3.7M
10.78%3.09M
25.71%4.95M
56.07%4M
2.19%11.65M
-27.79%2.35M
2.65%2.79M
115.65%3.94M
-28.67%2.56M
Operating expense
-16.14%87.54M
-39.17%16.32M
-31.34%20.02M
3.81%24.93M
7.71%26.26M
18.17%104.39M
10.97%26.82M
18.68%29.16M
18.98%24.02M
25.65%24.38M
Selling and administrative expenses
-13.40%25.2M
-43.36%4.7M
-21.68%5.45M
-21.26%5.53M
39.66%9.52M
21.78%29.11M
38.72%8.3M
7.70%6.96M
19.38%7.03M
22.45%6.81M
Research and development costs
-17.20%62.33M
-37.29%11.61M
-34.37%14.57M
14.17%19.4M
-4.68%16.75M
16.83%75.28M
1.84%18.52M
22.60%22.2M
18.82%16.99M
26.93%17.57M
Operating profit
22.59%-71.79M
48.45%-12.61M
35.80%-16.93M
0.49%-19.98M
-2.03%-22.26M
-20.54%-92.74M
-17.01%-24.47M
-20.68%-26.37M
-9.36%-20.08M
-37.99%-21.82M
Net non-operating interest income expense
-6.82%-3.26M
-43.01%-1.07M
-24.43%-927K
4.21%-683K
31.75%-574K
10.32%-3.05M
12.78%-751K
13.27%-745K
15.82%-713K
-0.84%-841K
Non-operating interest income
104.07%2.21M
-24.95%352K
39.77%485K
198.64%660K
1,480.00%711K
584.81%1.08M
1,102.56%469K
891.43%347K
569.70%221K
-11.76%45K
Non-operating interest expense
32.28%5.47M
16.89%1.43M
29.30%1.41M
43.79%1.34M
45.03%1.29M
16.10%4.13M
35.56%1.22M
22.15%1.09M
6.14%934K
0.11%886K
Other net income (expense)
109.03%87K
191.36%236K
-5,933.33%-175K
97.30%-29K
103.70%55K
-102.07%-963K
224.00%81K
-99.40%3K
-2,486.67%-1.07M
-99.94%27K
Other non- operating income (expenses)
109.03%87K
191.36%236K
-5,933.33%-175K
97.30%-29K
103.70%55K
-102.07%-963K
224.00%81K
-99.40%3K
-2,486.67%-1.07M
-99.94%27K
Income before tax
22.53%-74.96M
46.49%-13.45M
33.50%-18.03M
5.37%-20.69M
-0.65%-22.78M
-185.80%-96.75M
-15.59%-25.14M
-22.08%-27.11M
-14.11%-21.87M
-177.34%-22.63M
Income tax
-73.91%6K
166.67%2K
0
-88.24%2K
-77.78%2K
-64.06%23K
-116.67%-3K
0
54.55%17K
-52.63%9K
Net income
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
-177.42%-22.64M
Net income continuous Operations
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
-177.42%-22.64M
Minority interest income
Net income attributable to the parent company
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
-177.42%-22.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
-177.42%-22.64M
Basic earnings per share
27.19%-50.78
46.90%-9.08
33.87%-12.3
7.84%-14.1
18.75%-15.6
-132.47%-69.74
10.94%-17.1
4.62%-18.6
10.53%-15.3
-174.42%-19.2
Diluted earnings per share
27.19%-50.78
46.90%-9.08
33.87%-12.3
7.84%-14.1
18.75%-15.6
-132.47%-69.74
10.94%-17.1
4.62%-18.6
10.53%-15.3
-175.29%-19.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 16.98%15.77M41.06%3.8M-20.25%3.21M13.49%4.64M54.06%4.12M11.05%13.48M-19.76%2.7M32.41%4.02M95.09%4.09M-26.69%2.67M
Operating revenue 21.90%15.52M41.06%3.8M-20.25%3.21M31.49%4.39M54.06%4.12M4.88%12.73M-19.76%2.7M32.41%4.02M59.32%3.34M-26.69%2.67M
Cost of revenue -98.69%24K-70.72%101K-90.66%115K-305.30%-310K7.27%118K146.58%1.84M231.73%345K287.11%1.23M-44.07%151K107.55%110K
Gross profit 35.22%15.75M57.46%3.7M10.78%3.09M25.71%4.95M56.07%4M2.19%11.65M-27.79%2.35M2.65%2.79M115.65%3.94M-28.67%2.56M
Operating expense -16.14%87.54M-39.17%16.32M-31.34%20.02M3.81%24.93M7.71%26.26M18.17%104.39M10.97%26.82M18.68%29.16M18.98%24.02M25.65%24.38M
Selling and administrative expenses -13.40%25.2M-43.36%4.7M-21.68%5.45M-21.26%5.53M39.66%9.52M21.78%29.11M38.72%8.3M7.70%6.96M19.38%7.03M22.45%6.81M
Research and development costs -17.20%62.33M-37.29%11.61M-34.37%14.57M14.17%19.4M-4.68%16.75M16.83%75.28M1.84%18.52M22.60%22.2M18.82%16.99M26.93%17.57M
Operating profit 22.59%-71.79M48.45%-12.61M35.80%-16.93M0.49%-19.98M-2.03%-22.26M-20.54%-92.74M-17.01%-24.47M-20.68%-26.37M-9.36%-20.08M-37.99%-21.82M
Net non-operating interest income expense -6.82%-3.26M-43.01%-1.07M-24.43%-927K4.21%-683K31.75%-574K10.32%-3.05M12.78%-751K13.27%-745K15.82%-713K-0.84%-841K
Non-operating interest income 104.07%2.21M-24.95%352K39.77%485K198.64%660K1,480.00%711K584.81%1.08M1,102.56%469K891.43%347K569.70%221K-11.76%45K
Non-operating interest expense 32.28%5.47M16.89%1.43M29.30%1.41M43.79%1.34M45.03%1.29M16.10%4.13M35.56%1.22M22.15%1.09M6.14%934K0.11%886K
Other net income (expense) 109.03%87K191.36%236K-5,933.33%-175K97.30%-29K103.70%55K-102.07%-963K224.00%81K-99.40%3K-2,486.67%-1.07M-99.94%27K
Other non- operating income (expenses) 109.03%87K191.36%236K-5,933.33%-175K97.30%-29K103.70%55K-102.07%-963K224.00%81K-99.40%3K-2,486.67%-1.07M-99.94%27K
Income before tax 22.53%-74.96M46.49%-13.45M33.50%-18.03M5.37%-20.69M-0.65%-22.78M-185.80%-96.75M-15.59%-25.14M-22.08%-27.11M-14.11%-21.87M-177.34%-22.63M
Income tax -73.91%6K166.67%2K0-88.24%2K-77.78%2K-64.06%23K-116.67%-3K054.55%17K-52.63%9K
Net income 22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M-177.42%-22.64M
Net income continuous Operations 22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M-177.42%-22.64M
Minority interest income
Net income attributable to the parent company 22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M-177.42%-22.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M-177.42%-22.64M
Basic earnings per share 27.19%-50.7846.90%-9.0833.87%-12.37.84%-14.118.75%-15.6-132.47%-69.7410.94%-17.14.62%-18.610.53%-15.3-174.42%-19.2
Diluted earnings per share 27.19%-50.7846.90%-9.0833.87%-12.37.84%-14.118.75%-15.6-132.47%-69.7410.94%-17.14.62%-18.610.53%-15.3-175.29%-19.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg